Seven Mile Advisory Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$574K |
| 2 |
Microsoft
MSFT
|
+$311K |
| 3 |
NextEra Energy
NEE
|
+$259K |
| 4 |
Blackstone
BX
|
+$249K |
| 5 |
Elevance Health
ELV
|
+$244K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$248K |
| 2 |
Gilead Sciences
GILD
|
+$220K |
| 3 |
British American Tobacco
BTI
|
+$206K |
| 4 |
Sanofi
SNY
|
+$206K |
| 5 |
Unilever
UL
|
+$204K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.42% |
| 2 | Communication Services | 9.31% |
| 3 | Financials | 7.66% |
| 4 | Healthcare | 6.24% |
| 5 | Consumer Discretionary | 6.2% |
Similar funds
Seven Mile Advisory's Q4 2023 Portfolio in Review
As of Q4 2023, Seven Mile Advisory held 156 positions worth $115M, up 21% from $95.2M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Seven Mile Advisory deployed $8.01M of net new capital in Q4 2023, opening 28 new positions and adding to 77 existing holdings. Its largest new stake was NextEra Energy: 4,538 shares worth $276K.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $89.3K trimmed.
- Seven Mile Advisory's largest Q4 2023 buy was NextEra Energy: 4,538 shares worth $276K.
- Seven Mile Advisory added most to iShares Russell 1000 Growth ETF in Q4 2023, an estimated $574K increase.
- Seven Mile Advisory's biggest Q4 2023 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $89.3K.
- Seven Mile Advisory fully exited AstraZeneca in Q4 2023, selling an estimated $248K.
- Seven Mile Advisory's ten largest holdings make up 46% of its $115M portfolio in Q4 2023.
- Seven Mile Advisory opened 28 new positions and closed 6 in Q4 2023.
- Seven Mile Advisory's portfolio value rose 21% quarter-over-quarter to $115M.
Based on Seven Mile Advisory's 13F filing for Q4 2023, filed 9 Feb 2024.